Conclusions
Children with HLH who have a pSOFA score of ≥ 8, or are younger than 3 years, are at a higher risk of relapsed or refractory disease. These findings suggest a new application for the pSOFA score, which was recently proposed as a severity grading tool in consensus-based guidelines from the Histiocyte Society. Further evaluation of management strategies in this context is warranted.